Primary Aldosteronism: Screening and Treatment Essentials
March 2026
You’re in a key spot to help manage patients with primary aldosteronism (PA)...when adrenal glands make too much aldosterone.
This leads to problems, such as sodium retention, low potassium, and hypertension, which can increase cardiovascular and kidney disease risk.
Recent Endocrine Society guidelines suggest screening ALL patients with hypertension for PA.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive